Friday 6 November 2026 Export ILMN’s income statement to Excel — free account

Illumina, Inc.

ILMN Healthcare Diagnostics & Research

Illumina, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 0.66% from fiscal 2024.

Revenue: +4.15%
EPS: +49.0%
Free cash flow: +49.8%
Total debt: +80.0%

Quarter to September 2026, against a year earlier

212.61 4.61 +2.22%

Follow ILMN

Alert me

Market cap: $31.5B
P/E: 35.6×
Fwd P/E: 46.4×
Dividend yield: —
F-score: 8/9
Altman Z: 4.39
Beneish M: −2.51
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Illumina, Inc. 10-K filed Feb 12, 2025

Fiscal year 2024 · Period ended Dec 29, 2024 · Filed Feb 12, 2025 · accepted 4:21 PM ET · Document on sec.gov · Filing index

Red flags

Impairment Feb 12, 2025
Illumina, Inc. recorded a goodwill impairment of $1.5 billion in fiscal 2024

10-K filed Feb 12, 2025 · The filing · sec.gov

What changed

Item 1, Business Item 1A, Risk Factors Item 7, Management’s Discussion and Analysis

Item 1, Business: no comparison — the Item was not found